# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 03-26-2024 | 12-31-2023 | 10-K | |
2 | 11-14-2023 | 09-30-2023 | 10-Q | |
3 | 10-20-2023 | 06-30-2023 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Allurion Technologies (NYSE:ALUR) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $...
New data demonstrates 80% sustained weight loss at three years with the Allurion Program and initial positive outcomes of a nov...
Allurion Technologies' Virtual Care Suite (VCS) is now available to license in the United States for providers offering GLP...